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Abstract
Background: Adenoid Cystic Carcinoma of the lacrimal gland is a rare tumour. Their aggressive
behaviour, with a high-risk of local recurrence, and late distant spread of the tumour even after
aggressive management has been reported. Metastasis to the liver is rare and when it occurs, it is
usually part of widespread metastasis, and therefore surgical treatment is seldom considered.
Case presentation: We report a rare case of an isolated liver metastasis from a lacrimal gland
adenoid cystic carcinoma 20 years after resection of the primary tumour. The patient presented
with right upper quadrant pain radiating to the back and shortness of breath of 3 months duration.
No local recurrence was detected during a 15 year follow-up with computerized tomography (CT)
of the head. Abdominal CT scan demonstrated a solitary liver tumour with no other primary
source, and the bone scan was normal. The patient was treated with an extended right
hemihepatectomy. The histology revealed a predominantly cribriform tumour with focal areas of
basaloid type metastatic lacrimal gland adenoid cystic carcinoma.
Conclusion: This case illustrates the unpredictable behaviour of adenoid cystic carcinoma and the
need for a life long follow up for these patients after treatment. The possibility of surgical resection
for liver metastasis from adenoid cystic carcinoma should always be considered.
Background
Adenoid cystic carcinomas (ACC) of the lacrimal gland
are rare malignant tumours accounting for 1.6% of all
orbital tumours [1-3]. Despite their rarity they are the sec-
ond most frequent epithelial neoplasms occurring in the
lacrimal gland after pleomorphic adenomas [4].
They are slow growing tumours, which tend to spread to
adjacent structures and occasionally metastasise via hae-
matogenous spread to lungs, brain and bone in decreas-
ing order of frequency [5-8].
There are few studies and reports on lacrimal gland ACC
describing time interval to presentation of metastases and
length of follow-up required [9,10]. The liver is consid-
ered a rare site of distant metastasis and when it is
involved is usually as part of disseminated disease [7]. To
our knowledge, neither solitary liver metastasis, nor met-
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astatic liver resection from a lacrimal gland ACC has been
reported.
We present a case of an isolated liver metastasis occurring
20 years after initial surgery for lacrimal gland ACC, with
no evidence of loco regional, synchronous or meta-
chronous distant metastasis.
Case presentation
In 1985, a 51-year-old male, underwent a radical cranio-
facial resection for a left lacrimal gland adenoid cystic car-
cinoma, followed by postoperative radiotherapy. He was
followed-up with annual head and orbital CT scans for 15
years with no signs of loco-regional recurrence. Five years
after discharge from follow-up, he presented with a 3-
month history of right upper quadrant pain, radiating to
his back, associated with shortness of breath and reduced
exercise tolerance.
Physical examination revealed hepatomegaly and right
upper quadrant tenderness, but no stigmata of chronic
liver disease. Head and neck examination revealed no sign
of local recurrence. LFT, inflammatory markers, coagula-
tion profile, CEA, CA 19-9, and AFP were all normal. An
abdominal ultrasound (USS) examination and subse-
quent chest and abdominal CT scan showed a large 15 ×
17 × 20 cm heterogeneous mass with a central area of low
attenuation suggesting necrosis involving segments 4 to 8
of the liver (Figure 1), partially occluding the right portal
vein. No lung or bone metastases were identified.
The patient was otherwise fit with no other significant
past medical history. After discussion at our multidiscipli-
nary meeting the patient was offered surgery. At opera-
tion, the tumour was found to infiltrate the right hemi
diaphragm, which was locally excised en bloc with the
extended right hemihepatectomy. The postoperative
course was unremarkable and he was discharged 7 days
after surgery. The histology revealed a metastatic adenoid
cystic carcinoma identical to his primary lacrimal gland
tumour 20 years earlier, with prominent cribriform and
focal basaloid type areas (Figures 2 and 3).
Discussion
Adenoid cystic carcinomas (ACC) of the lacrimal gland
account for 1.6% of all orbital tumours [1-3]. Despite
being rare, it has a well-documented dismal prognosis
[11].
ACC in general has a slow biological growth and tends to
have a protracted course with a poor outcome, with a
reported survival rate of less than 50% at 5 years and 20%
at 10 years [11-14]. Lacrimal gland ACC displays a simi-
larly aggressive behavior with an overall survival of 20%
at 10 years [15,16]. Local recurrence risk was shown to be
higher than distant recurrence in 8 different studies
[8,17], suggesting local recurrence as the commonest
cause of disease progression and death.
Histologically, the liver tumour comprises nests of cells with  cylinderomatous microcystic spaces Figure 2
Histologically, the liver tumour comprises nests of cells with 
cylinderomatous microcystic spaces. These are filled with 
hyaline and basophilic mucoid material consistent with cribri-
form pattern of adenoid cystic carcinoma. Removal appears 
to be complete.
Portal venous phase image of an axial CT cut showing a large  heterogeneous cystic mass within the right lobe of the liver  centered on segment 5 and 6 and measuring 15 × 17 × 20 cm  in maximum dimension Figure 1
Portal venous phase image of an axial CT cut showing a large 
heterogeneous cystic mass within the right lobe of the liver 
centered on segment 5 and 6 and measuring 15 × 17 × 20 cm 
in maximum dimension. Further cuts show extension to seg-
ment 4A and segment 1 encroachment. No direct portal or 
peri-coeliac lymphadenopathy was identified.World Journal of Surgical Oncology 2006, 4:66 http://www.wjso.com/content/4/1/66
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In 23 years retrospective study, Ramon et al, reviewed the
outcome of 12 patients with low grade ACC, showing that
all patients had local recurrence with a mean interval of
3.25 years, and a mean survival of 5 years [18]. In the
Bayler series of patients with lacrimal gland ACC, the
longest survivors lived 13 and 16 years respectively after
exenteration and radiotherapy [9]. In this case our patient
is still alive 21 years after the primary resection.
Late presentation of distant metastases is a recognised fea-
ture of ACC with reported distant metastasis rates of 19–
24%, and a mean time to presentation of 7.6 years [8].
Recurrence after 16 years has been reported [19]; with
bone and lungs as the commonest sites for distant metas-
tases [5,8,11,20].
Metastasis to the liver is rare and usually only occurs in
conjunction with more widespread metastatic disease
[21]. Reported rates of liver metastases in ACC are
between 2–20%, with the longest reported period to pres-
entation of only 36 months [10,21]. No isolated hepatic
metastases from lacrimal gland ACC were recorded in
these series.
This patient had liver metastasis as the sole presentation
of secondary disease 20 years following treatment for his
primary with no evidence of local recurrence. Surgical
resection of liver metastasis from lacrimal gland ACC has
never been reported before.
There is no proven effective chemotherapy for the treat-
ment of metastatic lacrimal gland ACC; however some
studies suggested benefit from neoadjuvant and adjuvant
chemotherapy in the treatment of primary lacrimal gland
ACC, in terms of improving local disease control and
overall disease free survival [22].
This case highlights new aspects on ACC of the lacrimal
glands, and a new evidence of the unpredictability of ACC
behaviour in general.
Conclusion
Solitary hepatic metastasis can occur extremely late after
resection of lacrimal gland ACC. Life long follow-up of
patients with ACC is mandatory as treatable single organ
recurrence may occur decades after resection of the pri-
The tumour after complete resection Figure 5
The tumour after complete resection. Section of the previous resected lacrimal gland tumour in  1986 was retrieved and reviewed Figure 3
Section of the previous resected lacrimal gland tumour in 
1986 was retrieved and reviewed. This shows adenoid cystic 
carcinoma of identical pattern to the liver tumour.
The massive liver tumor at an early stage of the challenging  operation Figure 4
The massive liver tumor at an early stage of the challenging 
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mary. Resection of such liver metastasis is possible and
should be considered.
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